Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acne Keloidalis Nuchae: A Multicenter Retrospective Study of 142 Hispanic Patients.
Sánchez-Dueñas LE, Ungson-García MG, Ramírez-Sánchez JA, Barrera AMA, Machado MM, Ocampo-Garza SS, Rojano-Fritz LK, Gálvez-Canseco A, López LEB, Mendoza DG, Yepiz RC, Delgadillo AA, Miranda YM. Sánchez-Dueñas LE, et al. Among authors: ocampo garza ss. Dermatol Pract Concept. 2024 Jul 1;14(3):e2024198. doi: 10.5826/dpc.1403a198. Dermatol Pract Concept. 2024. PMID: 39122530 Free PMC article.
Off-label biologic treatments in refractory inflammatory scarring alopecia.
Aguilar-Calderón PE, Brussolo-Marroquin E, Riojas-Hernández ED, Gómez-Flores M, Ocampo-Candiani J, Ocampo-Garza SS. Aguilar-Calderón PE, et al. Among authors: ocampo garza ss. J Eur Acad Dermatol Venereol. 2024 Aug;38(8):e708-e710. doi: 10.1111/jdv.19851. Epub 2024 Feb 13. J Eur Acad Dermatol Venereol. 2024. PMID: 38348938 No abstract available.
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire.
Camela E, Villani A, Ocampo Garza SS, Costa C, Fabbrocini G, Megna M, Potestio L, Ruggiero A, Scalvenzi M. Camela E, et al. Among authors: ocampo garza ss. Dermatol Pract Concept. 2023 Jul 1;13(3):e2023177. doi: 10.5826/dpc.1303a177. Dermatol Pract Concept. 2023. PMID: 37557166 Free PMC article.
Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features.
Megna M, De Lucia M, Gallo L, Lauro W, Picone V, Fabbrocini G, Ocampo-Garza SS. Megna M, et al. Among authors: ocampo garza ss. Skin Appendage Disord. 2023 Jun;9(3):207-210. doi: 10.1159/000527985. Epub 2022 Dec 8. Skin Appendage Disord. 2023. PMID: 37325282 Free PMC article.
Hair Aging and Hair Disorders in Elderly Patients.
Villani A, Ferrillo M, Fabbrocini G, Ocampo-Garza SS, Scalvenzi M, Ruggiero A. Villani A, et al. Among authors: ocampo garza ss. Int J Trichology. 2022 Nov-Dec;14(6):191-196. doi: 10.4103/ijt.ijt_90_21. Epub 2023 Jan 31. Int J Trichology. 2022. PMID: 37034552 Free PMC article. Review.
Zosteriform leiomyomas after Herpes Zoster infection: the isotopic pathway.
Greco V, Miano C, Nocerino M, Potestio L, Fabbrocini G, Nappa P, Mascolo M, Russo D, Ocampo-Garza SS. Greco V, et al. Among authors: ocampo garza ss. Ital J Dermatol Venerol. 2023 Feb;158(1):60-61. doi: 10.23736/S2784-8671.22.07249-8. Ital J Dermatol Venerol. 2023. PMID: 36939502 No abstract available.
Towards Personalized Medicine in Psoriasis: Current Progress.
Camela E, Potestio L, Ruggiero A, Ocampo-Garza SS, Fabbrocini G, Megna M. Camela E, et al. Among authors: ocampo garza ss. Psoriasis (Auckl). 2022 Sep 1;12:231-250. doi: 10.2147/PTT.S328460. eCollection 2022. Psoriasis (Auckl). 2022. PMID: 36071793 Free PMC article. Review.
53 results